The bones grow naturally and undergo changes as the child grows up. During the process of growing up, abnormalities (such as aneurysmal bone cysts) may develop over a period of time. Aneurysmal bone cysts are benign tumors that do not spread. An aneurysmal bone cyst (ABC) may develop fibrous cysts filled with blood. It can cause severe swelling, pain, and fractures. Aneurysmal bone cysts are generally found in children at their teenage. Generally, these rare benign tumors are seen in childhood and early adulthood. Research findings suggest that approximately 90% of these lesions are found before the age of 30 years.
They can occur in virtually any bone; for example, the legs, the trunk, and the skull as well as on the knee and the vertebrae. ABC deforms a bone and it can cause major fractures. The skin temperature nearby the bone may rise and the body movements get restricted. Aneurysmal bone cysts (ABCs) were first described in 1942 by Dr. Jaffe and Dr. Lichenstein. These tumors are rare with an annual incidence rate of 0.32 per 100,000 individuals. A plain radiogram can give more information of osteolytic lesion, while magnetic resonance tomography can give an idea of overall fluid levels, blood sedimentation.
Request to View Brochure of Report –
The global Aneurysmal Bone Cysts (ABCs) Treatment Market is estimated to expand at a sluggish pace in the next few years. Some of the reasons driving the global aneurysmal bone cysts (ABCs) treatment market are increase in the incidence of primary lesions (which account for approximately 66% of all ABCs), rise in pediatric population, increase in investments in R&D by key players to develop a precise treatment for aneurysmal bone cysts, and growth in awareness about early diagnosis and treatment. Additionally, favorable reimbursement policies for surgical treatments in developed regions such as North America and Europe are likely to boost the global aneurysmal bone cysts (ABCs) treatment market in the near future. Consequently, high cost of treatment and side-effects of surgical treatments are some of the factors that restrain the market.
The global aneurysmal bone cysts (ABCs) treatment market can be divided based on treatment and geographical region. Based on treatment, the market has been segmented into curettage & bone grafting, marginal or wide excision, sclerotherapy, cryotherapy, and others. The curettage & bone grafting segment is estimated to expand rapidly in the next few years, as it is a very common treatment for aneurysmal bone cysts (ABCs). In this treatment, a surgical procedure is performed to remove cysts out of the bone by using a unique instrument termed as curette.
Request to View ToC of Report –
This instrument has a scoop or ring at its tip. The surgical procedure is known as curettage. In approximately 20% of the treated cases, aneurysmal bone cysts are found to recur. Hence, in several cases, doctors provide follow-up care after every three months during the first two years of the treatment. These follow-up procedures may involve managing disease complications and early screening of the recurrence of the cysts. A typical follow-up treatment may involve examination of the previous treatment, physical examination, and imaging scans.
Based on geography, the global aneurysmal bone cysts (ABCs) treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is estimated to expand rapidly in the next few years. Some of the reasons for the leading position of North America are well-developed health care systems, proper reimbursement scenario, and adoption of new and advanced techniques in the region. North America is estimated to be followed by Europe and Asia Pacific. Presence of key players, rise in investments in R&D activities by top players, and collaboration of key players with research institutes are some of the reasons driving the global aneurysmal bone cysts (ABCs) treatment market.
Enquiry for discount on this report –
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453